ZARAGOZA, Spain and FRANKLIN LAKES, N.J., Oct. 21, 2020 /PRNewswire/ -- CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today ...

BDX received IVDR approval for two VIASURE assays, expanding BD MAX respiratory and STI testing in Europe. New BD MAX tests detect COVID-19, flu, RSV, HSV-1/2 and syphilis using a fully automated ...

FRANKLIN LAKES, N.J., Aug. 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) ...

SPARKS, Maryland, May 12, 2014 /PRNewswire/ -- BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), announced today the availability of the CE-marked BD ...

The BioGX SARS-CoV-2 Reagents for BD MAX™ System is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the 2019-nCoV in nasopharyngeal and oropharyngeal swab samples ...

BD Diagnostics, a part of global medical technology company BD (Becton, Dickinson and Company), and Biodiversity SpA, a biotechnology company for molecular diagnostics, announced a regional ...

On Monday, global cases of the monkeypox virus topped 1,000, urging the Centers for Disease Control and Prevention to bump up its alert to level 2 and caution travelers to take extra precautions.

BD (Becton, Dickinson and Company), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular screening ...

The U.S. Food and Drug Administration (FDA) alerted clinical laboratory staff and health care providers of an increased risk of a false-positive result with BD SARS-CoV-2 Reagents for the BD Max ...

Please provide your email address to receive an email when new articles are posted on . The BD MAX Respiratory Viral Panel detected and differentiated between influenza A and B respiratory syncytial ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics portfolio in Europe. This follows the ...